HYFUSIN GROUP (08512) announced that its net profit for 2025 is approximately HK$101 million, a decrease of 40.81% year-on-year.
Cathay Pacific Group Holdings (08512) announced its performance in 2025, with revenue of approximately 898 million Hong Kong dollars, a decrease of 1.25% year-on-year; net profit of approximately 101 million Hong Kong dollars, a decrease of 40.81% year-on-year; and earnings per share of 11.05 Hong Kong cents.
HYFUSIN GROUP (08512) announces its performance in 2025, with revenue of approximately HK$898 million, a decrease of 1.25% year-on-year; net profit of approximately HK$101 million, a decrease of 40.81% year-on-year; and earnings per share of HK$0.1105.
Related Articles
PETRO-KING (02178) announced its performance for the year 2025. The company's owners are entitled to a profit of HKD 23.189 million, with a year-on-year turnaround from a loss to a profit.
China Railway Signal & Communication Corporation (03969) won five important projects in January and February with a total bid amount of approximately 8.92 billion yuan.
LEE'S PHARM(00950): Innovent obtains approval from the National Medical Products Administration.
PETRO-KING (02178) announced its performance for the year 2025. The company's owners are entitled to a profit of HKD 23.189 million, with a year-on-year turnaround from a loss to a profit.
China Railway Signal & Communication Corporation (03969) won five important projects in January and February with a total bid amount of approximately 8.92 billion yuan.
LEE'S PHARM(00950): Innovent obtains approval from the National Medical Products Administration.
